key: cord-0730838-fv42jhd2
authors: Reboiro, Manuel Lorenzo López; Fuentetaja, Rebeca Suárez; López, Raquel Gutiérrez; Castro-Conde, Beatriz Ares; González, Cristina Sardiña; Castro, José López; Menéndez, Inés Navarro; Barrionuevo, Marco Francisco Pereyra; Pérez, M. Teresa Alves
title: Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19
date: 2021-03-15
journal: J Infect
DOI: 10.1016/j.jinf.2021.03.006
sha: 4b030bb9acc0932ddd5cba78ba47158a08aedd45
doc_id: 730838
cord_uid: fv42jhd2

nan

limit of normal 150%). This is in agreement with the results reported by Falcinelli et al. 1 In addition, lupus anticoagulant (LA) testing was performed, with significantly higher values in patients requiring non-invasive mechanical ventilation (NIMV) as compared to those requiring conventional oxygen therapy only (1.41 ± 0.32 vs. 1.1 ± 0.07 IU; P = 0.024) (Figure 1a ). In 8 patients, LA values were higher than 1.1 IU and 4 of them needed NIMV, whereas none of the patients with LA levels < 1.1 IU required ventilatory support.

These data indicate that in addition to vWF and other molecules, such as fibrinogen, thrombin, and beta-2 glycoprotein I (beta-2 GPI), LA plays a crucial role in thrombogenesis induced by SARS-CoV-2 infection. Beta-2 GPI promotes LA activity, with platelet adhesion, aggregation, release of tissue factor and activation of the coagulation cascade (Figure 1b ), leading to a hypercoagulable state, which may be frequently irreversible in advanced stages. 5 On the other hand, the cytokine storm can amplify platelets' thrombotic response by increasing platelet production and development of disseminated microthrombi in different territories of the vasculature, with direct involvement in the pathogenesis of thrombosis in COVID-19. Another consequence is that high LA levels are directly related to a higher risk for prothrombotic complications, progression to the need of mechanical ventilation, and poor clinical outcome. The combination of both parameters, vWF and LA, would be a very useful predictive tool to assess the risk of hospitalization as well as to assess which patients would be candidates for mechanical ventilation or even to evaluate the risk of death. Therefore, it would be advisable to evaluate in prospective studies the possibility of routinely measuring serum levels of vWF and LA as prognostic predictive markers of severe COVID19 and at risk of acute respiratory distress syndrome. 6 Assessment of these parameters may contribute to determine which of the patients that recover from the acute phase of the disease will present chronic or permanent endothelial damage, and in some cases, for predicting reactivation in different microvasculature territories, such as vasa vasorum of the peripheral nerves and cerebral microvasculature causing a proinflammatory status (endotheliitis) 1 leading to chronic neuropathic or neuropsychiatric late sequelae.

Role of endotelial dysfunction in the thrombotic complications of COVID-19 patients

COVID-19 and thrombosis: Beyond a casual association

Post-COVID-19 syndrome (PC19S): chronic reactive endotheliitis and disseminated vascular disease

COVID-19: the vasculature unleashed

Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism

Post-coronavirus disease syndrome and disseminated microthrombosis: the role of von Willebrand factor and antiphospholipid antibodies

Role of lupus anticoagulant (LA) and von Willebrand factor (vWF) in thrombogenesis associated with SARS-CoV-2 infection

The authors declare no conflict of interest.

None to be declared.

The contribution of Drs Hermitas García Quiroga, Victor Manuel López Mouriño, and Enrique Álvarez Asensio with data collection, and Mrs. Charo Ibáñez González with the process database depuration is kindly acknowledged.